Wealth Advisors’s ProShares Ultra Health Care RXL Stock Holding History

Wealth Advisors’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-13,520	Closed	-$415K	–	87
2020 Q2	$415K	Hold	13,520	–	–	0.22%	46
2020 Q1	$378K	Buy	+13,520	New	+$389K	0.25%	45

Other funds holding RXL

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return

Wealth Advisors's RXL Position: Q3 2020 in Review

Wealth Advisors sold out of ProShares Ultra Health Care (RXL) in Q3 2020, closing a stake of 13,520 shares — an estimated $415K sold.

Wealth Advisors first reported a position in RXL in Q1 2020 and held it in 2 quarters. The position peaked at $415K in Q2 2020. 19 funds tracked by Wall St. Rank hold RXL as of Q3 2020.

Wealth Advisors reported no remaining ProShares Ultra Health Care position as of Q3 2020 after selling out during the quarter.
Wealth Advisors sold 13,520 ProShares Ultra Health Care shares in Q3 2020, an estimated $415K.
Wealth Advisors first reported a position in ProShares Ultra Health Care in Q1 2020 and held it in 2 quarters.
Wealth Advisors's ProShares Ultra Health Care position peaked at $415K in Q2 2020.
19 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q3 2020.

Based on Wealth Advisors's 13F filing for Q3 2020, filed 19 Oct 2020.